Many questions may arise when considering IVF treatment and infertility care. Below, you can find answers to frequently asked questions, from initial assessment and treatment stages to embryo development and factors affecting success.
This information is intended for general educational purposes. Each patient’s assessment and treatment plan is determined according to their individual medical circumstances.
1. Infertility and Initial Assessment
What Is Infertility?
Infertility refers to difficulty achieving or successfully maintaining a pregnancy.
For couples without a known fertility problem, an evaluation is generally recommended when pregnancy has not occurred after 12 months of regular, unprotected intercourse if the woman is under 35, or after 6 months if she is 35 or older.
For women over 40, or when conditions such as endometriosis, irregular ovulation, fallopian tube problems, or male-factor infertility are already known, an earlier evaluation may be appropriate.
What Causes Infertility?
Possible causes of infertility include ovulation disorders, blocked or damaged fallopian tubes, problems with sperm count or quality, structural abnormalities of the uterus, and endometriosis.
Female age is also an important factor affecting fertility. In some couples, no clear cause can be identified despite appropriate investigations. This is known as unexplained infertility.
What Happens During the First Consultation?
The initial consultation includes a review of how long the couple has been trying to conceive, menstrual history, previous pregnancies, past surgeries, medications, and existing medical conditions.
Depending on the circumstances, an ultrasound examination, ovarian reserve testing, assessment of fallopian tube patency, and semen analysis may be recommended.
Because infertility is not exclusively a female-related condition, evaluation of both partners is important when appropriate.
What Is Ovarian Reserve? What Does the AMH Test Show?
Ovarian reserve refers to the remaining pool of eggs in the ovaries.
An anti-Müllerian hormone (AMH) blood test and an ultrasound-based antral follicle count may help predict how the ovaries are likely to respond to fertility medications.
However, AMH alone does not reliably indicate egg quality or the likelihood of conceiving naturally. Results should be interpreted alongside age and other clinical findings.
2. Intrauterine Insemination and IVF
What Is Intrauterine Insemination (IUI)?
Intrauterine insemination involves placing a laboratory-prepared sperm sample directly into the uterus around the time of ovulation using a thin catheter.
The aim is to help sperm reach the egg. Appropriate sperm characteristics and the presence of at least one functional fallopian tube are among the factors that need to be assessed.
Who May Be Suitable for IUI?
IUI may be considered in certain ovulation disorders, mild male-factor infertility, and selected cases of unexplained infertility.
However, it may not be suitable when there are severe sperm abnormalities or both fallopian tubes are blocked.
What Is In Vitro Fertilization (IVF)?
In vitro fertilization is an assisted reproductive technique in which eggs are collected from the ovaries and fertilized with sperm in a laboratory. A developing embryo is then transferred into the uterus at an appropriate time.
Fertilization may be performed through conventional IVF or, when indicated, intracytoplasmic sperm injection (ICSI).
IUI or IVF: Which Is More Appropriate?
IUI is a less invasive assisted reproductive treatment and may be considered as an initial option for certain causes of infertility.
IVF may be considered when the fallopian tubes are severely damaged or blocked, significant male-factor infertility is present, or other treatments have been unsuccessful.
The choice depends on factors including female age, ovarian reserve, sperm characteristics, fallopian tube status, and the duration of infertility.
3. Stages of IVF Treatment
How Is IVF Performed?
IVF treatment generally involves five main stages:
- Ovarian stimulation: Medications are used to encourage the development of multiple follicles, with ultrasound monitoring.
- Egg retrieval (OPU): Eggs are collected from developing follicles, usually under ultrasound guidance and with sedation or anesthesia.
- Fertilization in the laboratory: Eggs are fertilized using conventional IVF or ICSI.
- Embryo development and monitoring: Developing embryos are observed in the laboratory.
- Embryo transfer: A suitable embryo is placed into the uterus using a thin catheter. In some cycles, embryos are frozen and transferred at a later date.
How Long Does IVF Treatment Take?
Ovarian stimulation and egg retrieval usually take approximately 10–14 days, although the duration varies between patients.
If a fresh embryo transfer is planned, it generally takes place a few days after egg retrieval. When embryos are frozen, transfer may be scheduled during a later menstrual cycle.
What Is ICSI? How Does It Differ From Conventional IVF?
In conventional IVF, eggs and sperm are brought together in a laboratory.
With ICSI, an embryologist selects a single sperm and injects it directly into a mature egg using a fine needle.
ICSI may be considered particularly in certain cases of male-factor infertility or previous fertilization problems. It cannot be assumed to improve pregnancy rates for every patient.
How Is Embryo Transfer Performed? Is It Painful?
During embryo transfer, a selected embryo is placed into the uterus through a thin catheter.
The procedure is usually brief and does not require anesthesia for most patients. Some may experience mild discomfort.
The details of the procedure and recommendations afterward depend on the individual treatment plan.
What Is Embryo Freezing? When Is It Used?
Embryo freezing involves preserving suitable embryos for future use using specialized laboratory techniques.
It may be considered when embryo transfer needs to be postponed or when additional suitable embryos are available.
Not every embryo will necessarily survive thawing and continue developing. Storage and use are subject to applicable regulations.
4. Success Rates, Risks, and Aftercare
What Is the Success Rate of IVF?
IVF success cannot be expressed as a single percentage.
Factors such as female age, ovarian reserve, egg and sperm characteristics, embryo development, the cause of infertility, and previous treatment history may influence the outcome.
A positive pregnancy test, clinical pregnancy, and live birth are different measures of success. It is therefore important to understand which outcome and patient population are being reported.
How Does Age Affect IVF Success?
Female age is one of the most important factors affecting IVF success, particularly when using a woman’s own eggs.
As age increases, the number of eggs and the likelihood of obtaining chromosomally normal eggs may decline. These changes become more pronounced particularly after the mid-30s.
However, an individual’s chances of success cannot be determined from age alone without a clinical assessment.
What Should I Do After Embryo Transfer?
Prolonged bed rest is generally not necessary after embryo transfer. Bed rest has not been shown to improve pregnancy rates.
Most patients can return to their normal daily activities. Recommendations from the treating medical team regarding physical activity and medication should be followed.
Is There a Risk of Multiple Pregnancy (Twins or Triplets)?
Yes. Transferring more than one embryo may increase the likelihood of multiple pregnancy. Rarely, twins may also occur after a single embryo transfer.
Multiple pregnancies carry higher risks of premature birth, low birth weight, and certain pregnancy complications.
The number of embryos transferred is determined according to individual patient characteristics and current regulations in Türkiye.
What Are the Side Effects and Risks of IVF?
Medications used for ovarian stimulation may cause injection-site discomfort, bloating, or other temporary symptoms.
Some patients may develop ovarian hyperstimulation syndrome (OHSS). Egg retrieval may rarely be associated with complications such as bleeding, infection, or injury to surrounding tissues.
The treatment process can also be emotionally demanding. Individual risks and measures to reduce them should be discussed before treatment.
What Happens If the First IVF Attempt Is Unsuccessful?
Failure to achieve pregnancy after the first IVF attempt does not mean that subsequent attempts will also be unsuccessful.
The ovarian response, number of eggs retrieved, fertilization and embryo development, transfer conditions, and other clinical factors are reviewed together.
Extensive additional testing or experimental treatments are not necessarily required after every unsuccessful attempt.
5. Embryo Assessment and Genetic Testing
How Is Embryo Quality Assessed?
Embryos are evaluated in the laboratory according to their developmental stage and microscopic appearance.
At the blastocyst stage, features such as the degree of expansion and the appearance of the inner cell mass and trophectoderm cells may be assessed.
However, an embryo’s morphological grade alone does not establish its chromosomal status or guarantee its potential to result in pregnancy.
What Are PGT-A, PGT-M, and PGT-SR?
Preimplantation genetic testing refers to methods used to assess specific genetic characteristics of embryos.
- PGT-A: Aims to evaluate differences in chromosome number.
- PGT-M: Used for specific single-gene disorders.
- PGT-SR: May be considered when a parent carries a structural chromosomal rearrangement.
These tests differ in their purpose, appropriate patient populations, and limitations.
PGT-A cannot be assumed to increase live birth rates for every patient.
What Does a Mosaic Embryo Result Mean After PGT-A?
A mosaic result is a laboratory finding suggesting that cells with different chromosomal characteristics may be present in the embryo biopsy sample.
This result may not accurately represent the genetic composition of the entire embryo.
Interpretation should take into account the testing method, report details, and genetic counseling.
6. Additional Tests and Laboratory Techniques
What Is the ERA Test? Is It Necessary for Everyone?
The endometrial receptivity analysis (ERA) test aims to assess the timing at which the uterine lining may be receptive to embryo implantation by examining gene expression.
However, there is insufficient evidence that routine ERA testing improves pregnancy or live birth outcomes. It is therefore not a standard test recommended for every patient.
What Is EmbryoGlue? Does It Work?
EmbryoGlue is a specialized embryo transfer medium containing hyaluronan.
It was developed to support the embryo transfer process.
Although some studies have reported potential benefits, the findings cannot be applied equally to all patients. Its use should be evaluated in light of current evidence and individual circumstances.
What Is Microfluidic Sperm Selection?
Microfluidic sperm selection is a laboratory technique that uses specialized microchannels to separate sperm according to characteristics such as motility.
It has not been conclusively demonstrated to improve live birth rates across all patient groups.
Research into the benefits of its routine use is ongoing.
What Is PICSI? How Does It Differ From Conventional ICSI?
Physiological intracytoplasmic sperm injection (PICSI) is a method that uses the ability of sperm to bind to hyaluronan as an additional selection criterion.
Unlike conventional ICSI, it incorporates an additional biological characteristic into sperm selection.
However, there is insufficient evidence that PICSI improves live birth rates for all patients.
What Is a Calcium Ionophore Used For?
A calcium ionophore is a laboratory agent that may be considered to support egg activation in certain fertilization problems.
It may be considered in selected cases where previous ICSI procedures resulted in no fertilization or very low fertilization rates.
It is not routinely used for every patient. Its potential benefits and safety should be assessed in the relevant clinical context.
Is Sperm DNA Fragmentation Testing Necessary?
Sperm DNA fragmentation testing aims to provide information about DNA integrity in sperm cells.
However, it is not routinely recommended for every man during an initial infertility evaluation.
It may be considered in specific clinical circumstances.
7. Experimental and Emerging Approaches
What Is Endometrial Scratching? Is It Beneficial?
Endometrial scratching involves a controlled mechanical injury to the uterine lining before embryo transfer.
Although it was proposed as a way to improve pregnancy outcomes, current scientific evidence does not support its routine use.
What Is PRP Treatment?
Platelet-rich plasma (PRP) is prepared from a person’s own blood.
Its possible effects on ovarian function and the uterine lining have been investigated in reproductive medicine.
However, there is insufficient evidence regarding its effectiveness and safety in infertility treatment, and it is not considered a standard treatment.
What Is Stem Cell Therapy?
The potential effects of stem cells on ovarian function and the uterine lining are being investigated.
These approaches are not established standard infertility treatments. Long-term human safety and effectiveness data remain limited.
What Is Exosome Therapy?
Exosomes are small structures released by cells that can carry various biological molecules.
Their potential roles in reproductive biology are being studied. However, exosome-based interventions are not standard infertility treatments, and their clinical effectiveness and safety have not been adequately established.
What Is ROSI?
Round spermatid injection (ROSI) is an experimental approach involving the injection of immature round spermatids into an egg instead of mature sperm cells.
It has been investigated in selected cases where mature sperm cannot be found.
ROSI is not a standard infertility treatment, and clinical evidence remains limited.
What Are Ovarian Rejuvenation and Mitochondrial Transfer?
Several experimental approaches are being investigated under the term ovarian rejuvenation.
Mitochondrial transfer is an advanced laboratory approach intended to influence egg cell function.
These methods have not been proven to reliably improve egg quality or increase live birth rates. Safety, ethical, and legal considerations are also important.
What Is Non-Invasive PGT?
Non-invasive preimplantation genetic testing aims to examine genetic material found in the embryo culture medium instead of obtaining cells through an embryo biopsy.
Research continues into its technical reliability, interpretation, and clinical benefits.
It has not replaced conventional embryo biopsy as a routinely recommended approach.
Do New Drugs Such as OXO-001 Improve IVF Success?
OXO-001 is an investigational drug candidate being studied for its potential effects on embryo implantation and reproductive outcomes.
Although research findings are of interest, the effectiveness and safety of such treatments require evaluation in larger clinical studies.
An investigational medication should not be presented as a routinely recommended treatment or as approved for use in Türkiye.
Final Note
Infertility assessment and IVF treatment do not follow the same pathway for every couple. Age, reproductive health findings, previous treatments, and individual circumstances influence treatment planning.
It is important to stay informed about new tests and laboratory techniques. However, not every new approach has been scientifically validated or shown to benefit every patient.
This page is intended for general educational purposes and does not replace an individual medical assessment, diagnosis, or treatment recommendation.